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VARIABILITY IN THE CRITERIA FOR EARLY 
SWITCH AND EARLY DISCHARGE IN 
COMMUNITY-ACQUIRED PNEUMONIA: A 
SYSTEMATIC REVIEW OF THE LITERATURE
Rhew DC1,2, Tu GS1, Ofman J1, Henning JM3, Richards MS3, 
Weingarten SR1
1Zynx Health Inc., Cedars-Sinai, Departments of Medicine and 
Health Services Research, Beverly Hills, CA, USA; 2West Los 
Angeles VA Medical Center, Los Angeles, CA, USA; 3TAP 
Holdings Inc., Deerfield, IL, USA
Strategies to achieve early switch from intravenous to
oral antibiotics and early discharge (ES
) for patients
with community-acquired pneumonia (CAP) are imple-
mented in an attempt to improve quality and efficiency of
care. A systematic review of ES
 criteria has not been
previously performed. OBJECTIVES: To assess differen-
tial features of ES
 criteria in the published literature.
METHODS: We searched MEDLINE, HEALTHSTAR,
EMBASE, COCHRANE COLLABORATION, and BEST
EVIDENCE databases from 1980–1999 for CAP studies
that included specific switch criteria or recommendations
to switch on a particular day. Explicit inclusion and ex-
clusion criteria were applied to titles, abstracts, and arti-
cles. Physician reviews were done in duplicate, with dis-
agreement resolved by consensus. RESULTS: From 3666
titles identified, 305 abstracts were reviewed. Of 85 arti-
cles selected, 62 (73%) were retrieved and reviewed. We
identified 12 prospective interventional CAP-specific stud-
ies. Switch criteria included: resolution of fever (67%),
improving respiratory signs and/or symptoms (50%),
ability to take oral medications (50%), normalization of
white blood cell count (33%), “clinical stability” (NOS)
(33%), minimal IV treatment (25%), hemodynamic sta-
bility (25%), no other sites of infection (25%), unaltered
mental status (17%), and stable or improving radio-
graphic findings (8%) (reviewer kappa, 1.0). Nine differ-
ent criteria combinations were applied in the 12 studies.
Four studies applied separate criteria for early discharge:
care for comorbid conditions (75%), need for diagnostic
work-up (25%), social needs (25%), and clinical stability
during observation (25%) (kappa  1.0). Three different
discharge criteria combinations were applied in 4 studies.
A specific post-switch antibiotic was recommended in 8
(67%) studies, specific day for switch (median, day 3) in
7 (58%) studies, and specific day for discharge (median,
day 4) in 4 (33%) studies. CONCLUSION: Systematic
review reveals that there is considerable variability in
ES
 criteria, which may promote uncertainty regarding
the interpretation of results from ES
 studies.
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COSTS AND OUTCOMES OF A RESPIRATORY 
SYNCYTIAL VIRUS PROPHYLAXIS PROGRAM IN 
A MEDICAID MANAGED CARE ORGANIZATION
Schaffer M, Amaya MA, Vojta D
Health Partners, Philadelphia, PA, USA
Respiratory Syncytial Virus (RSV) is a known cause of
morbidity in premature infants, as well as those with
bronchopulmonary dysplasia. OBJECTIVE: To measure
the impact of a RSV prophylaxis program on pulmonary-
related hospitalizations (PRH), average length-of-stay
(ALOS), and cost/immunized member to a Medicaid man-
aged care plan. METHODS: Through administrative claims
we identified members at risk for RSV infection based on
American Academy of Pediatrics (AAP) guidelines for
RSV prophylaxis. Baselines were determined for PRH
rate and ALOS for two seasons prior to intervention (N 
452). We identified 205 high-risk infants eligible for pro-
phylaxis. Physicians were mailed a list of their eligible
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